SGLT2 Inhibitors: Basic Training Quiz

The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.


Early results also found an inverse relationship between serum CT levels and estimated glomerular filtration rate.

Not all patients with type 2 diabetes respond equally to GLP-1 receptor agonists. Results of a recent study suggest what to look for before you write that next Rx.

New endocrinology drugs

Since June of 2014, the US FDA has approved a number of drugs for a variety of endocrine-related diseases. Here are 10 of them.

While we are increasingly evaluated on numbers—A1c, blood pressure, LDL—these parameters are largely outside of our direct control. Mr M is a case in point.

There are pros and cons to using SGLT2 inhibitors in the elderly. Are you familiar with both? Find out with 7 quick multiple choice questions.

John is an active older man whose A1c has gone from 6.8% to 7.6% since his last follow-up visit. He refuses to get involved in any “needle business.” What’s next?

Four questions for you to answer, four facts you need to know.


Subscribe to Diabetes on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.